GI Effects is unlike any other stool analysis profile, going beyond the standard parameters for identifying gastrointestinal disorders.
The GI Effects Profile uses DNA analysis to identify microbiota including anaerobes, a previously immeasurable area of the gut environment. DNA assessment is specific and accurate, avoids the pitfalls of sample transport, reports results as specific numbers, and is more sensitive than classic laboratory methods.
Download the White Paper on documented limitations of culture based stool assessment.
Over 99% of the bacteria in the gut are anaerobes, but in the cecum, aerobic bacteria reach high densities. Under normal homeostatic conditions, the intestinal microflora are of central importance in preventing colonization by pathogens, termed “colonization resistance.” Microorganisms perform a host of useful functions, such as fermenting unused energy substrates, communicating with the immune system, preventing growth of harmful species, regulating the development of the gut, producing vitamins for the host (such as biotin and vitamin K), and producing hormones.
The Microbial Profile focuses on predominate, opportunistic, and pathogenic bacteria, as well as yeast/fungi, parasites, adiposity index, and microbial and fungi sensitivities. The Microbial Profile is also an easy and cost-effective follow-up testing option to monitor targeted therapy in patients.
"PCR is the best developed and most widely used nucleic acid amplification strategy...These techniques have sensitivity unparalleled in laboratory medicine, have created new opportunities for the clinical laboratory to have an effect on patient care and have become the new "gold standards" for laboratory diagnosis of several infectious diseases."
-Manual of Clinical Microbiology, 8th Edition, Vol. 1, page 235, 2003